PDUFA Date Extended for Aldeyra’s Reproxalap Dry Eye NDA Aldeyra Therapeutics a biotechnology company focused on the discovery and development of innovative therapies for immune-mediated and inflammatory diseases, has announced…
Natera and MEDSIR Partner on MiRaDoR Trial to Advance Genome-Guided Treatment Strategies in HR+/HER2- Breast Cancer Natera a global leader in cell-free DNA (cfDNA) testing and precision medicine, and MEDSIR…
Summit Therapeutics Issues Inducement Awards Pursuant to Nasdaq Listing a biopharmaceutical company focused on developing innovative therapies for serious diseases, today announced the issuance of inducement equity awards in the…
The American Headache Society® (AHS)—a leading professional organization committed to advancing the science, education, and clinical practice of headache and facial pain medicine—has announced plans to host the 2025 Scottsdale…
MedTech Innovator Names Powerful Medical and Wavelet as Winners of the 2025 Mid-Stage Grand Prize and Value Award MedTech Innovator , recognized as the world’s largest accelerator dedicated to advancing…
The German Brain Foundation: Strengthening Neurological Awareness, Care, and Research with RHÖN-KLINIKUM Campus Bad Neustadt as a New Member Neurological diseases represent one of the most significant healthcare challenges of…
UnitedHealth Group Announces Appointment of Former FDA Commissioner Dr. Scott Gottlieb to Its Board of Directors UnitedHealth Group has announced that Dr. Scott Gottlieb, a distinguished physician, health policy expert,…
Neurogene Reports Third Quarter 2025 Financial Results and Provides Comprehensive Clinical and Corporate Updates a clinical-stage biotechnology company dedicated to delivering transformative genetic medicines for patients with rare neurological disorders,…
Adapt Upgrade Reflects Significant Debt Reduction and Improved Recovery Outlook, Says S&P Global Adapt Health a nationwide provider of patient-centered healthcare-at-home services, announced that S&P Global Ratings has upgraded the…
Acuitas Therapeutics Showcases Next-Generation LNP Breakthroughs at the 2025 International mRNA Health Conference Acuitas Therapeutics, a global leader in lipid nanoparticle (LNP) delivery technologies, unveiled its Next-Generation LNP advancements at…
Rating reflects ongoing commitment to patient safety and quality care Northwell Health has once again demonstrated its leadership in patient safety and clinical excellence, with fifteen of its hospitals receiving…
Dia Medica Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate and Clinical Updates Dia Medica Therapeutics, a clinical-stage biopharmaceutical company developing novel treatments for preeclampsia (PE), fetal growth…